| Long name: |
SKIL Polyclonal Antibody |
| Antigen: |
SKIL |
| Synonim names: |
SnoA, SnoI, SnoN, SNO |
| Other names: |
SKI-like oncogene, SKI-like proto-oncogene, Ski-like protein, Ski-related oncogene, Ski-related protein, ski-like protein, ski-related oncogene snoN, ski-like protein isoform 1 |
| Gene name: |
SKIL, SKIL |
| Gene synonims: |
SKIL, SNO, SNO, SnoA, SnoI, SnoN, SKIL |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
SKIL, This is an antibody designed to detect SKIL |
| Purification method: |
This antibody was purified via antigen affinity purification method |
| Concentration: |
1, 8mg/mL |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, IFA, Immunohistochemistry (IHC), Western Blot (WB), ELISA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
SKIL |
| Short name: |
Anti- SKIL Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to v-ski sarcoma viral oncogene homolog (avian)-like oncogene (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007283 and spermatogenesis and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0010467 and gene expression and biological process this GO :0016605 and PML body and cellular component this GO :0019904 and protein domain specific binding and molecular function this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0032403 and protein complex binding and molecular function this GO :0034097 and response to cytokine and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043234 and protein complex and cellular component this GO :0045596 and negative regulation of cell differentiation and biological process this GO :0046332 and SMAD binding and molecular function this GO :0046677 and response to antibiotic and biological process this GO :0050772 and positive regulation of axonogenesis and biological process this GO :0070207 and protein homotrimerization and biological process this GO :0070208 and protein heterotrimerization and biological process this GO :0070306 and lens fiber cell differentiation and biological process this GO :0070848 and response to growth factor and biological process this GO :1902043 and positive regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :1902231 and positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage and biological process, SKIL and IDBG-636450 and ENSBTAG00000004154 and 527910, SKIL and IDBG-64482 and ENSG00000136603 and 6498, SMAD binding, SNO and SnoA and SnoI and SnoN, Skil and IDBG-136318 and ENSMUSG00000027660 and 20482, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001669 and acrosomal vesicle and cellular component this GO :0001825 and blastocyst formation and biological process this GO :0002260 and lymphocyte homeostasis and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003714 and transcription corepressor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006351 and transcription, this GO :0003682 : chromatin binding, this GO :0003682 : chromatin binding and also this GO :0003714 : transcription corepressor activity and also this GO :0005515 : protein binding and also this GO :0019904 : protein domain specific binding and also this GO :0032403 : protein complex binding and also this GO :0046332 : SMAD binding, this GO :0003714 : transcription corepressor activity, this GO :0005515 : protein binding, this GO :0019904 : protein domain specific binding, this GO :0032403 : protein complex binding, this GO :0046332 : SMAD binding, SKI-like oncogene |
| Identity: |
10897 |
| Gene: |
SKIL |
More about : SKIL |
| Long gene name: |
SKI like proto-oncogene |
| Synonyms gene name: |
SKI-like oncogene |
| Synonyms: |
SNO SnoN SnoA |
| Locus: |
3q26, 2 |
| Discovery year: |
1997-11-28 |
| GenBank acession: |
X15217 |
| Entrez gene record: |
6498 |
| Pubmed identfication: |
2762147 |
| RefSeq identity: |
NM_005414 |
| Classification: |
SKI transcriptional corepressors |
| Havana BLAST/BLAT: |
OTTHUMG00000158831 |